Gilead steps into breach left by AbbVie as Galapagos' partner

Gilead Sciences has earmarked $2bn to take a stake in Belgium's Galapagos and buy into its filgotinib drug candidate for rheumatoid arthritis.

Merck finally bags FDA approval for Bridion

The US FDA has approved Merck & Co's Bridion to reverse the effects of neuromuscular blockade induced by muscle relaxants used during surgery.

ArchiMed acquires life sciences consultancy Deallus

ArchiMed, Europe's first independent private equity healthcare specialist, has acquired majority control of Deallus Consulting.